On subsequently examining the frequency of clonal vs. subclonal driver mutation events between the sexes, we found that while there were differences in the proportions of truncal mutations (e.g. 100% of TERT promoter mutations were truncal events in male-derived vs. 50% truncal events in female-derived thyroid cancer patients), no comparisons were statistically significant. Here, TERT is linked to thyroid gland carcinoma.